KALM Therapeutics, Inc.

New Filing
CIK: 0002032945·Biotechnology·DELAWARE·Filed: Aug 9, 2024
Total Offering

$590,380

Amount Sold

$590,380

Investors

14

First Sale

Jul 25, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
Chris Seibert
Related Person
Anuj Singhal
Related Person

Company

KALM Therapeutics, Inc.

6820 MOQUIN DRIVE NW

HUNTSVILLE, AL, 35806

(256) 715-9336

SEC Filing

0002032945-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
KALM Therapeutics, Inc. Form D Filing — $590,380 | FilingFlow